Healx
UK - CambridgeBiotechnology
Focus: Healx is an AI-driven drug discovery company focused on rare diseases and neurology, leveraging computational platforms to identify novel therapeutic candidates. Founded in 2005 and headquartered in Cambridge, UK, the company operates as a public-stage biotech with a specialized mission in unmet rare disease populations.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
1-1 this month
Stable — net -1 jobs in 30d
0 added, 1 removed. Backfill posture.
Should You Work at Healx?
AI assessmentHealx offers compelling AI-biotech credentials and rare-disease focus for specialists, but thin hiring signals and opaque financials warrant due diligence on runway and growth trajectory.
Why Work Here
- Access to cutting-edge AI/ML drug discovery infrastructure positioned at the frontier of computational therapeutics—a high-growth specialty attracting top computational talent.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Help build intelligence for Healx
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.